Company intelligence

Alzamend Neuro

BiotechActive
We're still building this profile — here is what Pulse has covered.

Latest Pulse

  1. Three Biotechs File S-1s in the Same WeekTempest Therapeutics, Aptevo Therapeutics and Alzamend Neuro all filed S-1 registration statements this week, a reminder that the biotech IPO pipeline keeps moving even in a news cycle dominated by trillion-dollar AI listings.→

Coverage Timeline

newest first
  1. IPOThree Biotechs File S-1s in the Same Week→

All Coverage

IPO

Three Biotechs File S-1s in the Same Week

Related Companies

Same sector
Attovia TherapeuticsApnimedBraveheart BioLatigo BiotherapeuticsScribe Therapeutics